Your browser doesn't support javascript.
loading
Observer-masked trial comparing efficacy of topical olopatadine (0.1%), bepotastine (1.5%), and alcaftadine (0.25%) in mild to moderate allergic conjunctivitis.
Dudeja, Lakshey; Janakiraman, Anuja; Dudeja, Ishani; Sane, Kaustubh; Babu, Manohar.
Afiliación
  • Dudeja L; Medical Consultant, Department of Cornea and Refractive Surgery, Aravind Eye Hospital, Salem, Tamil Nadu, India.
  • Janakiraman A; Medical Consultant, Department of Cornea and Refractive Surgery, Aravind Eye Hospital, Salem, Tamil Nadu, India.
  • Dudeja I; Comprhensive Ophthalmology Fellow, Aravind Eye Hospital, Salem, Tamil Nadu, India.
  • Sane K; Fellow in the Department of Cornea, Aravind Eye Hospital, Salem, Tamil Nadu, India.
  • Babu M; Chief Medical Officer, Aravind Eye Hospital, Salem, Tamil Nadu, India.
Indian J Ophthalmol ; 67(9): 1400-1404, 2019 09.
Article en En | MEDLINE | ID: mdl-31436181
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Piperidinas / Piridinas / Benzazepinas / Conjuntivitis Alérgica / Clorhidrato de Olopatadina / Imidazoles Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Indian J Ophthalmol Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Piperidinas / Piridinas / Benzazepinas / Conjuntivitis Alérgica / Clorhidrato de Olopatadina / Imidazoles Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Indian J Ophthalmol Año: 2019 Tipo del documento: Article